127 related articles for article (PubMed ID: 12555142)
1. Signaling pathways that influence extracellular remodeling.
Lee RT; Lammerding J
J Card Fail; 2002 Dec; 8(6 Suppl):S339-43. PubMed ID: 12555142
[TBL] [Abstract][Full Text] [Related]
2. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
[TBL] [Abstract][Full Text] [Related]
3. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Spinale FG
Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
[TBL] [Abstract][Full Text] [Related]
4. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
Deschamps AM; Spinale FG
Cardiovasc Res; 2006 Feb; 69(3):666-76. PubMed ID: 16426590
[TBL] [Abstract][Full Text] [Related]
5. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
[TBL] [Abstract][Full Text] [Related]
6. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
Schram K; Sweeney G
Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
[TBL] [Abstract][Full Text] [Related]
7. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
Cleutjens JP; Creemers EE
J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
[TBL] [Abstract][Full Text] [Related]
8. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
9. The extracellular connections: the role of integrins in myocardial remodeling.
Ross RS
J Card Fail; 2002 Dec; 8(6 Suppl):S326-31. PubMed ID: 12555140
[TBL] [Abstract][Full Text] [Related]
10. Myocardial proteases and matrix remodeling in inflammatory heart disease.
Rutschow S; Li J; Schultheiss HP; Pauschinger M
Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
[TBL] [Abstract][Full Text] [Related]
12. The dynamic interaction of the extracellular matrix in cardiac remodeling.
Goldsmith EC; Borg TK
J Card Fail; 2002 Dec; 8(6 Suppl):S314-8. PubMed ID: 12555138
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and failure From molecules to man (Part II).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase inhibition and the prevention of heart failure.
Lee RT
Trends Cardiovasc Med; 2001 Jul; 11(5):202-5. PubMed ID: 11597832
[TBL] [Abstract][Full Text] [Related]
15. Preservation of cardiac extracellular matrix by passive myocardial restraint: an emerging new therapeutic paradigm in the prevention of adverse remodeling and progressive heart failure.
Shah PK
Circulation; 2005 Aug; 112(9):1245-7. PubMed ID: 16129809
[No Abstract] [Full Text] [Related]
16. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Janssens S; Lijnen HR
Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
[TBL] [Abstract][Full Text] [Related]
17. Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure.
Sackner-Bernstein JD
Med Hypotheses; 2002 Jan; 58(1):18-23. PubMed ID: 11863394
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
[TBL] [Abstract][Full Text] [Related]
19. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
20. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
